Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
We recently reported that mice deficient in the programmed cell death-1 (PD-1) immunoinhibitory coreceptor develop autoimmune dilated cardiomyopathy (DCM), with production of high-titer autoantibodies against a heart-specific, 30-kDa protein. In this study, we purified the 30-kDa protein from heart extract and identified it as cardiac troponin I (cTnI), encoded by a gene in which mutations can cause familial hypertrophic cardiomyopathy (HCM). Administration of monoclonal antibodies to cTnI induced dilatation and dysfunction of hearts in wild-type mice. Monoclonal antibodies to cTnI stained the surface of cardiomyocytes and augmented the voltage-dependent L-type Ca2+ current of normal cardiomyocytes. These findings suggest that antibodies to cTnI induce heart dysfunction and dilatation by chronic stimulation of Ca2+ influx in cardiomyocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the cardiotoxicity of anti-cTnI autoantibodies has been reported in studies using BALB/c mice lacking PD-1 expression”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“PD-1-deficient BALB/c mice spontaneously developed autoimmune DCM mediated by anti-cTnI antibodies, and the pathology was transferable when wild-type mice were treated with these autoantibodies”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“suggesting a potential mechanism of ICI myocarditis.”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“the cardiotoxicity of anti-cTnI antibodies has been reported in PD-1 -/- BALB/c mice”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
In the citing paper
“However, these autoantibodies are generally not disease-specific and may not consistently induce the disease phenotype in murine models, indicating their limitations as diagnostic and therapeutic targets. 57,92,97,191”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [97]
Citations
Cites
Hamill, O. P., Marty, A., Neher, E., Sakmann, B., & Sigworth, F. J. (1981) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00656997 · Cited by 18,436
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Self-citationThe Genetic Basis for Cardiomyopathy
Seidman, J. G., & Seidman, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,046
Calcium tolerant ventricular myocytes prepared by preincubation in a ?KB medium?
Isenberg, G., & Klockner, U. (1982) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00584963 · Cited by 898
Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy
Kamisago, M., Sharma, S. D., DePalma, S. R., Solomon, S., Sharma, P., McDonough, B., Smoot, L., Mullen, M. P., Woolf, P. K., Wigle, E. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432304 · Cited by 720
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
Kimura, A., Harada, H., Park, J.-E., Nishi, H., Satoh, M., Takahashi, M., Hiroi, S., Sasaoka, T., Ohbuchi, N., Nakamura, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0897-379 · Cited by 577
Cardiac myosin induces myocarditis in genetically predisposed mice.
Neu, N., Rose, N. R., Beisel, K. W., Herskowitz, A., Gurri-Glass, G., & Craig, S. W. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.11.3630 · Cited by 526
Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12
Shou, W., Aghdasi, B., Armstrong, D. L., Guo, Q., Bao, S., Charng, M.-J., Mathews, L. M., Schneider, M. D., Hamilton, S. L., & Matzuk, M. M. (1998) · Nature · doi:10.1038/35146 · Cited by 431
Cited by
Items 301–400 of 688
Longinow, J., Zmaili, M. A., Skoza, W. A., Kondoleon, N. P., Marquardt, R. J., Calabrese, C. M., Funchain, P., & Moudgil, R. (2022) · Cancer Medicine · doi:10.1002/cam4.5050 · Cited by 33
Hayashi, T., Tiwary, S. K., Lavine, K. J., Acharya, S., Brent, M. R., Adamo, L., Kovács, A. D., & Mann, D. L. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.05.006 · Cited by 36
Adriouch, S., Franck, E., Drouot, L., Bonneau, C., Jolinon, N., Salvetti, A., & Boyer, O. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00199 · Cited by 22
Immunopathological Basis of Virus‐induced Myocarditis
Maier, R., Krebs, P., & Ludewig, B. (2004) · Journal of Immunology Research · doi:10.1080/10446670410001670427 · Cited by 35
Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapy
Buehning, F., Lerchner, T., Vogel, J., Hendgen-Cotta, U. B., Totzeck, M., Rassaf, T., & Michel, L. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01070-0 · Cited by 31
The Role of B-Cells in Heart Failure
Cordero‐Reyes, A. M., Youker, K. A., & Torre‐Amione, G. (2013) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-9-1-15 · Cited by 32
Increases in Serum Autoantibodies After Left Ventricular Assist Device Implantation
Grosman‐Rimon, L., Ajrawat, P., Lioe, J., Tumiati, L. C., Rao, V. A., Billia, F., & Chruscinski, A. J. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.01.002 · Cited by 29
Cone, E. B., Haeuser, L., Reese, S. W., Marchese, M., Nguyen, D., Nabi, J., Chou, W. H., Noldus, J., McKay, R. R., Kilbridge, K. L., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272022 · Cited by 32
Spleen associated immune-response mediates brain-heart interaction after intracerebral hemorrhage
Li, W., Li, W., Li, W., Chopp, M., Venkat, P., Zacharek, A., Chen, J., Landschoot‐Ward, J., & Chen, J. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113209 · Cited by 32
Brown, S.-A. N., Ray, J. C., & Herrmann, J. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-09992-5 · Cited by 32
Matsumoto, Y., Tsukada, Y., Miyakoshi, A., Sakuma, H., & Kohyama, K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3535 · Cited by 29
Huang, S., Kang, Y., Liu, T., Xiong, Y., Yang, Z., & Zhang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1561968 · Cited by 30
Epigenetic Modification of PD-1/PD-L1-Mediated Cancer Immunotherapy against Melanoma
Nanamori, H., & Sawada, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031119 · Cited by 29
Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies
Ronen, D., Bsoul, A., Lotem, M., Abedat, S., Yarkoni, M., Amir, O., & Asleh, R. (2022) · Vaccines · doi:10.3390/vaccines10040540 · Cited by 29
Advances in immune checkpoint inhibitors induced-cardiotoxicity
Li, X., Peng, W., Wu, J., Yeung, S. J., & Yang, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1130438 · Cited by 30
Reduction and activation of circulating dendritic cells in patients with decompensated heart failure
Sugi, Y., Yasukawa, H., Kai, H., Fukui, D., Futamata, N., Mawatari, K., Oba, T., Nagata, N., Kyougoku, S., Koga, M., et al. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.09.524 · Cited by 28
Dörner, A., Grunert, H. ‐., Lindig, V., Chandrasekharan, K., Fechner, H., Knowlton, K. U., Isik, A., Pauschinger, M., Zeichhardt, H., & Schultheiß, H. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0076-y · Cited by 28
Rikhi, R. R., Karnuta, J. M., Hussain, M., Collier, P. H., Funchain, P., Tang, W. H. W., Chan, T. A.-T., & Moudgil, R. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.721333 · Cited by 28
Molecular mapping of autoimmune B cell responses in experimental myocarditis
Krebs, P., Kurrer, M. O., Kremer, M., de Giuli, R., Sonderegger, I., Henke, A., Maier, R., & Ludewig, B. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.01.003 · Cited by 28
Nagatomo, Y., Li, D. Y., Kirsop, J., Borowski, A. G., Thakur, A., & Tang, W. H. W. (2016) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2016.03.005 · Cited by 27
Spallarossa, P., Meliota, G., Brunelli, C., Arboscello, E., Ameri, P., Dessalvi, C. C., Grossi, F., Deidda, M., Mele, D., Sarocchi, M., et al. (2017) · Medicinal Research Reviews · doi:10.1002/med.21478 · Cited by 28
Immune Checkpoint Inhibitors: Cardiotoxicity in Pre-clinical Models and Clinical Studies
Xu, S., Sharma, U. C., Tuttle, C., & Pokharel, S. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.619650 · Cited by 29
Shimozaki, K., Sukawa, Y., Sato, Y., Horie, S., Chida, A., Tsugaru, K., Togasaki, K., Kawasaki, K., Hirata, K., Hayashi, H., et al. (2021) · Future Oncology · doi:10.2217/fon-2020-0861 · Cited by 31
Sun, J.-Y., Qu, Q., Lou, Y.-X., Yang, H., Sun, G.-Z., Sun, W., & Kong, X. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.09.041 · Cited by 28
Cancer therapeutics-related cardiovascular dysfunction: Basic mechanisms and clinical manifestation
Oikawa, M., Ishida, T., & Takeishi, Y. (2022) · Journal of Cardiology · doi:10.1016/j.jjcc.2022.04.006 · Cited by 27
Figueira, E. A., de Rezende, M. L. R., Torres, S. A., Garlet, G. P., Lara, V. S., Santos, C. F., Ávila-Campos, M. J., Silva, J. S., & Campanelli, A. P. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.090057 · Cited by 28
Kessler, E. L., Oerlemans, M. I. F. J., van den Hoogen, P., Yap, C., Sluijter, J. P. G., & de Jager, S. C. A. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10026-3 · Cited by 30
Cardiac Toxicity Associated with Cancer Immunotherapy and Biological Drugs
Montisci, A., Vietri, M. T., Palmieri, V., Sala, S., Donatelli, F., & Napoli, C. (2021) · Cancers · doi:10.3390/cancers13194797 · Cited by 28
del Rio, M., Penuelas‐Rivas, G., Domínguez‐Perles, R., Ramírez, P., Parrilla, P., & Rodríguez-Barbosa, J.-I. (2005) · European Journal of Immunology · doi:10.1002/eji.200535232 · Cited by 31
Agents targeting inflammation in heart failure
Gullestad, L. L., KJEKSHUS, J. K., Damås, J. K., Ueland, T., Yndestad, A., & Aukrust, P. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.5.557 · Cited by 27
Coinhibitory T-Cell Signaling in Islet Allograft Rejection and Tolerance
Truong, W., Hancock, W. W., Anderson, C. C., Merani, S., & Shapiro, A. M. J. (2006) · Cell Transplantation · doi:10.3727/000000006783982160 · Cited by 30
Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors?
Totzeck, M., Lutgens, E., & Neilan, T. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa959 · Cited by 27
Bhardwaj, G., Dörr, M., Sappa, P. K., Ameling, S., Dhople, V. M., Steil, L., Klingel, K., Empen, K., Beug, D., Völker, U., et al. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.09.001 · Cited by 26
Baba, A. (2008) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2008.00555.x · Cited by 26
Mechanisms of T-cell inhibition: implications for cancer immunotherapy
Mittendorf, E. A., & Sharma, P. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.144 · Cited by 27
Epitope Specificity and IgG Subclass Distribution of Autoantibodies to Cardiac Troponin
Savukoski, T., Twarda‐Clapa, A., Hellberg, S., Ristiniemi, N., Wittfooth, S., Sinisalo, J. P., & Pettersson, K. S. I. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.194860 · Cited by 26
Myocardial and Pericardial Toxicity Associated With Immune Checkpoint Inhibitors in Cancer Patients
Chahine, J., Collier, P. H., Maroo, A. P., Tang, W. H. W., & Klein, A. L. (2020) · JACC Case Reports · doi:10.1016/j.jaccas.2019.11.080 · Cited by 27
Inhibitory costimulation and anti-tumor immunity
Martín‐Orozco, N., & Dong, C. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.06.003 · Cited by 26
Dennert, R. M., van Paassen, P., Wolffs, P. F. G., Bruggeman, C. A., Velthuis, S., Felix, S., van Suylen, R. J., Crijns, H. J. G. M., Tervaert, J. W. C., & Heymans, S. R. B. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00281-12 · Cited by 29
Suppression of IL-22–Producing T Helper 22 Cells by RPE Cells via PD-L1/PD-1 Interactions
Sugita, S., Kawazoe, Y., Imai, A., Usui, Y., Takahashi, M., & Mochizuki, M. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12703 · Cited by 27
Genetic factors in the pathogenesis of cardio-oncology
Qi, Y., Wei, Y., Li, L., Ge, H., Wang, Y., Zeng, C., & Ma, F. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05537-5 · Cited by 27
Development of troponin autoantibodies in experimental coxsackievirus B3 myocarditis
Latva‐Hirvelä, J., Kytö, V., Saraste, A., Eriksson, S., Vuorinen, T., Pettersson, K. S. I., & Saukko, P. J. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02113.x · Cited by 24
Case of pembrolizumab-induced myocarditis presenting as torsades de pointes with safe re-challenge
Lee, D. H., Armanious, M. A., Huang, J. Y., Jeong, D. K., Druta, M., & Fradley, M. G. (2020) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155220904152 · Cited by 25
Okuno, D., Sugiura, Y., Sakamoto, N., Tagod, M. S. O., Iwasaki, M., Noda, S., Tamura, A., Senju, H., Umeyama, Y., Yamaguchi, H., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01405 · Cited by 25
Self-citationTun, K. S. K., Setiady, Y. Y., Samy, E. T., Lewis, J., & Teuscher, C. (2005) · Springer eBooks · doi:10.1007/3-540-27702-1_10 · Cited by 24
PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease
Juchem, K. W., Sacirbegovic, F., Zhang, C., Sharpe, A. H., Russell, K. S., McNiff, J. M., Demetris, A. J., Shlomchik, M. J., & Shlomchik, W. D. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701076 · Cited by 23
The intracellular cation channel TMEM176B as a dual immunoregulator
Hill, M., Russo, S., Olivera, D., Malcuori, M., Galliussi, G., & Segovia, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1038429 · Cited by 26
Targeting Inflammation in the Diagnosis, Management, and Prevention of Cardiovascular Diseases
Matsumori, A. (2022) · Global Heart · doi:10.5334/gh.1156 · Cited by 25
Self-citationMatsumori, A. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2219895 · Cited by 27
Self-citationPinto, B. B., & Ackland, G. L. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.12.017 · Cited by 24
Immune checkpoint inhibitor-associated cardiovascular toxicities: A review
Liu, G., Chen, T., Zhang, X., Hu, B., & Shi, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25747 · Cited by 43
Takata, S., Nakamura, H., Umemoto, S., Yamaguchil, K., Sekine, T., Kato, T., Nishioka, K., & Matsuzaki, M. (2004) · Circulation Journal · doi:10.1253/circj.68.677 · Cited by 23
Athanassopoulos, P., Balk, A. H. M. M., Vaessen, L. M. B., Çalişkan, K., Takkenberg, J. J. M., Weimar, W. W., & Bogers, A. J. J. C. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.10.031 · Cited by 23
Lung cancer as a cardiotoxic state: a review
Pérez-Callejo, D., Torrente, M., Brenes, M. A., Núñez, B., & Provencio, M. (2017) · Medical Oncology · doi:10.1007/s12032-017-1012-4 · Cited by 23
Cardio-toxicity of checkpoint inhibitors
Müller, O. J., Spehlmann, M. E., & Frey, N. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.12.78 · Cited by 25
上野, 敦., Murasaki, K., Hagiwara, N., & Kasanuki, H. (2007) · Heart and Vessels · doi:10.1007/s00380-007-0977-x · Cited by 23
Immune Checkpoints and Innate Lymphoid Cells—New Avenues for Cancer Immunotherapy
Jacquelot, N., Ghaedi, M., Warner, K., Chung, D. C., Crome, S. Q., & Ohashi, P. S. (2021) · Cancers · doi:10.3390/cancers13235967 · Cited by 23
The role of IL-6, IL-10, TNF-α and PD-1 expression on CD4 T cells in atrial fibrillation
Bai, W., Liu, Z., He, P., & Muhuyati (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18818 · Cited by 22
Immune-mediated adverse effects of immune-checkpoint inhibitors and their management in cancer
Jin, K., Wang, S., Ying, X., Lan, H., Lv, J., Zhang, L.-H., Motallebnezhad, M., & Mou, X. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.02.008 · Cited by 24
Sagrero‐Fabela, N., Chávez-Mireles, R., Salazar‐Camarena, D. C., & Palafox‐Sánchez, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147726 · Cited by 22
Kallwellis-Opara, A., Staudt, A., Trimpert, C., Noutsias, M., Kühl, U., Pauschinger, M., Schultheiß, H., Grube, M., Böhm, M., Baumann, G., et al. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0263-5 · Cited by 21
Cancer immunotherapy harnessing γδ T cells and programmed death‐1
Tanaka, Y. (2020) · Immunological Reviews · doi:10.1111/imr.12917 · Cited by 21
Self-citationWong, C., Lam, T.-H., Liao, S.-Y., Lau, Y., Tse, H., & So, B. Y. F. (2023) · Biomedicines · doi:10.3390/biomedicines11010107 · Cited by 23
Lessomo, F. Y. N., Mandizadza, O. O., Mukuka, C., & Wang, Z. (2023) · European journal of medical research · doi:10.1186/s40001-023-01464-1 · Cited by 24
Cardiac Troponin I Autoantibody Induces Myocardial Dysfunction by PTEN Signaling Activation
Wu, Y. C., Qin, Y., Liu, Y., Zhu, L. X., Zhao, X., Liu, Y., Luo, S., Tang, G., & Shen, Q. (2019) · EBioMedicine · doi:10.2139/ssrn.3411043 · Cited by 22
Suarez-Almazor, M. E., Pundole, X., Abdel‐Wahab, N., Johnson, D. B., Gupta, D., Glezerman, I. G., Cooksley, T., Anderson, R., Blidner, A. G., Choi, J. N., et al. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05710-8 · Cited by 22
Autoantibodies and Cardiovascular Dysfunction: Cause or Consequence?
Nagatomo, Y., & Tang, W. H. W. (2014) · Current Heart Failure Reports · doi:10.1007/s11897-014-0217-5 · Cited by 22
Han, Y., Liao, X., Gao, Z., Yang, S., Chen, C., Liu, Y., Wang, W. E., Wu, G., Chen, X., José, P. A., et al. (2016) · Clinical Science · doi:10.1042/cs20160373 · Cited by 21
Kaku, H., & Rothstein, T. L. (2009) · Genes and Immunity · doi:10.1038/gene.2009.68 · Cited by 27
Li, J. (2024) · Wiley eBooks · doi:10.1002/9781683674023.ch95 · Cited by 21
Fleischer, S., Nash, T. R., Tamargo, M. A., Lock, R. I., Venturini, G., Morsink, M. A. J., Graney, P. L., Li, V., Lamberti, M. J., Liberman, M., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00525-w · Cited by 22
Agonist-like autoantibodies against calcium channel in patients with dilated cardiomyopathy
Xiao, H., Wang, M., Du, Y., Yuan, J., Zhao, G., Tu, D., & Liao, Y. (2011) · Heart and Vessels · doi:10.1007/s00380-011-0176-7 · Cited by 20
Autoantibodies Against Cardiac Troponin I in Patients with Congestive Heart Failure
Düngen, H., Platzeck, M., Vollert, J. O., Searle, J., Müller, C., Reiche, J., Mehrhof, F. B., Müller, R., & Möckel, M. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq088 · Cited by 20
Algaze, S. D., Park, W., Harrington, T. J., & Mudad, R. (2018) · BMJ Case Reports · doi:10.1136/bcr-2017-221801 · Cited by 20
The knowns and unknowns of cardiac autoimmunity in viral myocarditis
Mone, K., & Reddy, J. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2478 · Cited by 19
“In support of this notion, administration of anti ‐ cTNI antibodies have been shown to induce DCM in animal studies, 220,287,288 whereas β 1 ‐ AR antibodies could result in the prolonged activation of β 1 ‐ adreno receptors leading to hyperadrenergic state resulting in apoptosis, fibrosis and heart…”
Cardiovascular adverse effects of immunotherapy in cancer: insights and implications
Du, H., Wang, J., & Wang, Z. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1601808 · Cited by 22
Self-citationEmerging role of immune checkpoint inhibitors and their relevance for the cardiovascular system
Michel, L., Totzeck, M., Lehmann, L., & Finke, D. (2020) · Herz · doi:10.1007/s00059-020-04954-8 · Cited by 20
Programmed cell death-1 deficiency results in atrial remodeling in C57BL/6 mice
Fu, G., Cao, Y., Lu, J. G., Li, J., Liu, L., WANG, H., Su, F., & Zheng, Q. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1218 · Cited by 21
Autoimmunity Against Cardiac Troponin I in Ischaemia Reperfusion Injury
Volz, H. C., Buss, S. J., Li, J., Göser, S., Andrassy, M., Öttl, R., Pfitzer, G., Katus, H. A., & Kaya, Z. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr098 · Cited by 19
Regulatory T Cells in B Cell Follicles
Chang, J., & Chung, Y. (2014) · Immune Network · doi:10.4110/in.2014.14.5.227 · Cited by 20
Yoshikawa, T. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0373 · Cited by 21
Mechanisms and Management of Immune Checkpoint Inhibitor-Related Cardiac Adverse Events
Kadowaki, H., Akazawa, H., Ishida, J., & Komuro, I. (2021) · JMA Journal · doi:10.31662/jmaj.2021-0001 · Cited by 20
Gilon, D., Iakobishvili, Z., & Leibowitz, D. W. (2022) · Vaccines · doi:10.3390/vaccines10020304 · Cited by 19
Dendritic cells and autoimmune heart failure
Marty, R. R., & Eriksson, U. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.06.022 · Cited by 19
Wang, Y., Singh, K., Lokman, A. B., Deng, S., Sunitha, B., Lima, J. C., Jr., Beglov, J., Kelly, M., Blease, A., Fung, J. C. K., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adq3516 · Cited by 19
The PD-1/PD-L1 Pathway: A Perspective on Comparative Immuno-Oncology
Schöniger, S., & Jasani, B. (2022) · Animals · doi:10.3390/ani12192661 · Cited by 24
Milutinovic, S., Jancic, P., Jokić, V., Petrović, M., Dumic, I., Rodriguez, A. M., Tanasijevic, N., Begosh-Mayne, D., Stanojević, D., Escarcega, R. O., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17101372 · Cited by 20
Ylänen, K., Poutanen, T., Savukoski, T., Eerola, A., & Vettenranta, K. K. (2014) · Acta Paediatrica · doi:10.1111/apa.12862 · Cited by 18
Samejima, Y., Iuchi, A., Kanai, T., Noda, Y., Nasu, S., Tanaka, A., Morishita, N., Suzuki, H., Okamoto, N., Harada, H., et al. (2020) · Internal Medicine · doi:10.2169/internalmedicine.4550-20 · Cited by 19
Polymorphisms of Genes for Programmed Cell Death 1 Ligands in Patients with Rheumatoid Arthritis
Wang, S., Lin, C.-H., Li, R., Ou, T., Wu, C., Tsai, W., Liu, H., & Yen, J. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9113-z · Cited by 18
Cardiac Autoantibodies in Viral Myocarditis
Dörner, A., Kallwellis-Opara, A., Pauschinger, M., Kühl, U., & Schultheiß, H. (2005) · Heart Failure Clinics · doi:10.1016/j.hfc.2005.06.010 · Cited by 18
Racine, J. J., Bachman, J. F., Zhang, J.-G., Misherghi, A., Khadour, R., Kaisar, S., Bedard, O., Jenkins, C., Abbott, A., Forte, E., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300841 · Cited by 17
Cancer-Related Immune Therapies
Miteva, K., Anker, M. S., Fechner, H., Lehmann, L., & Linthout, S. V. (2025) · JACC CardioOncology · doi:10.1016/j.jaccao.2025.06.008 · Cited by 18
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis
Inno, A., Tarantini, L., Parrini, I., Spallarossa, P., Maurea, N., Bisceglia, I., Silvestris, N., Russo, A. D., & Gori, S. (2023) · Current Oncology Reports · doi:10.1007/s11912-023-01411-7 · Cited by 17
Aguilar, S. V., Cui, M., Tan, W. H., Sanchez‐Ortiz, E., Bassel‐Duby, R., Liu, N., & Olson, E. N. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00447-7 · Cited by 20
Heart failure in cancer: role of checkpoint inhibitors
Delgobo, M., & Frantz, S. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.10.07 · Cited by 18
Kanno, S., & Hara, A. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11752 · Cited by 20
Programmed Death-Ligand 2 Deficiency Exacerbates Experimental Autoimmune Myocarditis in Mice
Li, S., Tajiri, K., Murakoshi, N., Xu, D., Yonebayashi, S., Okabe, Y., Yuan, Z., Feng, D., Inoue, K., Aonuma, K., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031426 · Cited by 18
Cardiovascular oncology: exploring the effects of targeted cancer therapies on atherosclerosis
Seijkens, T. T. P., & Lutgens, E. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000538 · Cited by 17
The Significance of Autoimmunity in Myocarditis
Rose, N. R. (2006) · Springer eBooks · doi:10.1007/3-540-30822-9_9 · Cited by 18
Metadata
- Authors
- Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M., Hiai, H., Matsumori, A., Minato, N., & Honjo, T.
- Affiliations
- Kyoto University (JP)
- Mie University (JP)
- Corresponding author
- Honjo, Tasuku
- ORCID
- Venue
- Nature Medicine
- Published
- 2003-11-02
- Volume
- 9
- Issue
- 12
- Pages
- 1477-1483
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2140419562
- Semantic Scholar
- 8b8bf12ad1a303d244e325c58410b356c4ed2945
- Cited by
- 689
- References
- 38
- Citations by year
- 2026: 24 · 2025: 30 · 2024: 44 · 2023: 36 · 2022: 49 · 2021: 49 · 2020: 47 · 2019: 46 · 2018: 28 · 2017: 30 · 2016: 32 · 2015: 19 · 2014: 20 · 2013: 22 · 2012: 16
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- cardiac troponin I, autoantibodies, dilated cardiomyopathy, PD-1 deficiency, autoimmune cardiomyopathy, familial hypertrophic cardiomyopathy, L-type calcium current, cardiac dysfunction, monoclonal antibodies
- MeSH terms
- Animals, Antibodies, Monoclonal, Antigens, Surface, Autoantibodies, Base Sequence, Cardiomyopathy, Dilated, Humans, Mice, Inbred A, Mice, Inbred BALB C, Mice, Nude, Antigens, CD, Rats, Wistar, DNA, Complementary, Mice, Knockout, Troponin I, Calcium Signaling, Myocytes, Cardiac, Apoptosis Regulatory Proteins, Mice, Rats, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.